Similar results were obtained with the macrocyclic thiazole antibiotic Siomycin A (Fig 7D–7F), initially identified as an inhibitor of the transcription factor FOXM1b and thereafter reported to reduce MELK expression in brain tumor stem-like cells in vitro [52–54]. The gene discussed is FOXM1; the disease is brain neoplasm.